Aerin Medical Inc., a leader in minimally invasive solutions for chronic nasal conditions, today announced the launch of its next-generation RhinAer(R) device as well as UnitedHealthcare's Medicare ...

NEW ORLEANS -- Laser ablation of the posterior nasal nerve provided durable relief from rhinitis, and use of rhinitis medications decreased substantially, results of a small prospective series showed.

Aerin Medical Inc., a leader in minimally invasive solutions for chronic nasal conditions, today announced the publication of long-term results from a multicenter study evaluating the safety and ...

The Food and Drug Administration (FDA) has cleared Neuromark™ Rhinitis Neurolysis Therapy™ for otorhinolaryngology surgery for creation of radiofrequency lesions to disrupt posterior nasal nerves in ...

NEW YORK (CBSNewYork)-- Do you suffer with a chronic itchy, stuffy, runny nose that you just can't get rid of, even with medications? There may be relief for you with a new office procedure. CBS2's Dr ...

Please provide your email address to receive an email when new articles are posted on . The RhinAer system generates and applies 4 W of 60°C temperature-controlled bipolar radiofrequency energy to the ...

Please provide your email address to receive an email when new articles are posted on . 45.2% of patients who had “nasal allergies” had chronic rhinosinusitis. Patients with CRS tended to be older ...

— G.W.T.Dear G.W.T.: The sinus of the heart has nothing to do with your nose as you might guess; it's a structure in the ...

AUSTIN, Texas--(BUSINESS WIRE)--Aerin Medical Inc., a company focused on minimally invasive solutions for chronic nasal conditions, today announced U.S. Food and Drug Administration (FDA) clearance ...

MOUNTAIN VIEW, Calif., September 04, 2025--(BUSINESS WIRE)--Aerin Medical Inc., a leader in minimally invasive solutions for chronic nasal conditions, today announced the publication of long-term ...

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Aerin Medical Inc., a leader in minimally invasive solutions for chronic nasal conditions, today announced the publication of long-term results from a ...